Subscribe

2002 IDSA Guidelines for a Cancer Patient with Neutropenia Who Is Afebrile After Initial Empiric Antibiotic Therapy

Specialty:

Infectious Diseases
Clinical Pharmacology & Toxicology
Hematology Oncology

Objective:

ICD-10:

Description:

A cancer patient with febrile neutropenia is evaluated after the first 3 to 5 days of empiric therapy. If the patient is afebrile then further therapy can be adjusted or discontinued. The authors are from the Infectious Diseases Society of America (IDSA) and multiple hospitals in the North America and Europe.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone